Targeting Dimethylarginine Dimethylaminohydrolases in Pulmonary Arterial Hypertension: A New Approach to Improve Vascular Dysfunction?

Eitemau Tebyg

• Hepatic Dimethylarginine-Dimethylaminohydrolase1 is Reduced in Cirrhosis and is a Target for Therapy in Portal Hypertension
  gan: Mookerjee, Rajeshwar P, et al.
  Cyhoeddwyd: (2014)
• Overexpression of Dimethylarginine Dimethylaminohydrolase Protects against Cerebral Vascular Effects of Hyperhomocysteinemia
  gan: Rodionov, Roman N., et al.
  Cyhoeddwyd: (2009)
• Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
  gan: Prisco, Sasha Z., et al.
  Cyhoeddwyd: (2020)
• Effects of Dimethylarginine Dimethylaminohydrolase–1 Overexpression on the Response of the Pulmonary Vasculature to Hypoxia
  gan: Bakr, Adel, et al.
  Cyhoeddwyd: (2013)
• A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia
  gan: Trittmann, JK, et al.
  Cyhoeddwyd: (2016)